Table 2.
Unadjusted and adjusted Cox regression analysis for 1 year and long‐term mortality in the (A) FRAGILE‐HF and (B) Kitasato cohorts
| (A) | ||||||
|---|---|---|---|---|---|---|
| Groups | Unadjusted | Adjusted model a | ||||
| HR | 95% CI | P‐value | HR | 95% CI | P value | |
| Non‐slow group | 1 (Reference) | 1 (Reference) | ||||
| Slow group | 1.80 | 1.30–2.48 | <0.001 | 1.54 | 1.09–2.18 | 0.014 |
| (B) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Groups | 1 year mortality | Long‐term mortality | ||||||||||
| Unadjusted | Adjusted model b | Unadjusted | Adjusted model b | |||||||||
| HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | |
| Non‐slow group | 1 (Reference) | 1 (Reference) | 1 (Reference) | 1 (Reference) | ||||||||
| Slow group | 2.17 | 1.42–3.31 | <0.001 | 1.70 | 1.07–2.72 | 0.024 | 1.87 | 1.39–2.51 | <0.001 | 1.46 | 1.05–2.02 | 0.024 |
CI, confidence interval; HR, hazard ratio.
a
Adjusted for MAGGIC risk score and log‐transformed BNP at discharge.
b
Adjusted for age, male sex, body mass index, current smoker or not, systolic blood pressure, New York Heart Association class at discharge, left ventricular ejection fraction, history of diabetes, chronic obstructive pulmonary disease, and heart failure, creatinine at discharge, prescription of a beta‐blocker, or angiotensin converting enzyme inhibitor/angiotensin II receptor blocker at the time of discharge.